Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial-Reference-Cited by-同舟云学术

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Published:2006-02 Issue:2 Volume:17 Page:289-296
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Karthaus M.,Kretzschmar A.,Kröning H.,Biakhov M.,Irwin D.,Marschner N.,Slabber C.,Fountzilas G.,Garin A.,Abecasis N.G.F.,Baronius W.,Steger G.G.,Südhoff T.,Giorgetti C.,Reichardt P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/2/289/392328/mdj059.pdf

Reference39 articles.

1. Plegmasia alba dolens. In Trousseau A (ed.): Lectures on Clinical Medicine, delivered at the Hotel-Dieu, Paris. Cormack JR, trans. London: New Syndenham;Trousseau;Society,1872

2. Molecular basis for the relationship between thrombosis and cancer;Rickles;Thromb Res,2001

3. The thrombophilic state induced by therapeutic agents in the cancer patient;Lee;Semin Thromb Hemost,1999

4. Thrombotic complications of central venous catheters in cancer patients;Bona;Semin Thromb Hemost,1999

5. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients;Verso;J Clin Oncol,2003

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort study;Thrombosis Research;2024-04

2. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults;Cochrane Database of Systematic Reviews;2022-07-18

3. Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey;European Journal of Clinical Pharmacology;2022-06-17

4. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults;COCHRANE DB SYST REV;2022

5. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis;Thrombosis Research;2021-12